These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12795493)

  • 1. Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications.
    Jerrell JM
    Schizophr Bull; 2002; 28(4):589-605. PubMed ID: 12795493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
    Taylor DM; Wright T; Libretto SE;
    J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cost, dosage and clinical preference for risperidone and olanzapine.
    Rabinowitz J; Lichtenberg P; Kaplan Z
    Schizophr Res; 2000 Dec; 46(2-3):91-6. PubMed ID: 11120420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.
    Kelly DL; Nelson MW; Love RC; Yu Y; Conley RR
    Psychiatr Serv; 2001 May; 52(5):676-8. PubMed ID: 11331805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost evaluation of risperidone compared with olanzapine.
    Byerly MJ; Weber M; Brooks D; Casey SB; Elliot S; Hawkins J
    Psychiatr Serv; 2003 May; 54(5):742-4. PubMed ID: 12719509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.
    Zhao Z
    Manag Care Interface; 2002 Feb; 15(2):75-81. PubMed ID: 11875967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluations of olanzapine and risperidone.
    Shaw JW
    Am J Health Syst Pharm; 2002 Jul; 59(14):1366-75. PubMed ID: 12132564
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
    Del Paggio D; Finley PR; Cavano JM
    Clin Ther; 2002 May; 24(5):803-17. PubMed ID: 12075948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.
    Edgell ET; Andersen SW; Johnstone BM; Dulisse B; Revicki D; Breier A
    Pharmacoeconomics; 2000 Dec; 18(6):567-79. PubMed ID: 11227395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
    Rascati KL; Johnsrud MT; Crismon ML; Lage MJ; Barber BL
    Pharmacoeconomics; 2003; 21(10):683-97. PubMed ID: 12828491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.
    Bokszanska A; Martin G; Vanstraelen M; Holt G; Bouras N; Taylor D
    Int Clin Psychopharmacol; 2003 Sep; 18(5):285-91. PubMed ID: 12920389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
    Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
    J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
    de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
    J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Service use and costs of treating schizophrenia with atypical antipsychotics.
    Lewis M; McCrone P; Frangou S
    J Clin Psychiatry; 2001 Oct; 62(10):749-56. PubMed ID: 11816863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.
    Tunis SL; Faries DE; Nyhuis AW; Kinon BJ; Ascher-Svanum H; Aquila R
    Value Health; 2006; 9(2):77-89. PubMed ID: 16626411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of the treatment of schizophrenia in the UK. A simulation model comparing olanzapine, risperidone and haloperidol.
    Almond S; O'Donnell O
    Pharmacoeconomics; 2000 Apr; 17(4):383-9. PubMed ID: 10947493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone compared with olanzapine in a naturalistic clinical study in Ireland: a cost analysis.
    Lucey JV; Libretto SE
    Ir J Med Sci; 2003; 172(4):195-201. PubMed ID: 15029989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.